Ainos, Inc. (AIMD)
NASDAQ·Healthcare·Biotechnology
$1.80
-2.17%
Mkt Cap $7.14M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 30, 2026 | — | $11.12K | — | — | -$0.85 | — | — | — |
| Q4 2025 Nov 13, 2025 | — | $2.17K | — | — | -$0.64 | — | — | — |
| Q3 2025 Aug 13, 2025 | — | $4.66K | — | — | -$0.99 | — | — | — |
| Q2 2025 May 12, 2025 | — | $106.21K | — | — | -$1.05 | — | — | — |
| Q1 2025 Mar 7, 2025 | — | — | — | — | -$1.30 | — | — | — |
| Q4 2024 Nov 6, 2024 | — | — | — | — | -$1.65 | — | — | — |
| Q3 2024 Aug 5, 2024 | — | — | — | — | -$2.45 | — | — | — |
| Q2 2024 May 13, 2024 | — | $20.73K | — | — | -$2.85 | — | — | — |
| Q1 2024 Mar 8, 2024 | — | $19.90K | — | — | -$1.37 | — | — | — |
| Q1 2024 Feb 7, 2024 | — | $24.49K | — | — | -$0.73 | — | — | — |
| Q3 2023 Aug 11, 2023 | — | $28.55K | — | — | -$3.00 | — | — | — |
| Q2 2023 May 12, 2023 | — | $49.16K | — | — | -$3.25 | — | — | — |
| Q1 2023 Mar 31, 2023 | — | $1.04M | — | — | -$2.75 | — | — | — |
| Q4 2022 Nov 7, 2022 | — | $1.76M | — | — | -$12.75 | — | — | — |
| Q3 2022 Aug 15, 2022 | — | $636.63K | — | — | -$0.25 | — | — | — |
| Q2 2022 May 16, 2022 | — | $87.20K | — | — | -$3.75 | — | — | — |
| Q1 2022 Mar 21, 2022 | — | $26.40K | — | — | -$0.01 | — | — | — |
| Q4 2021 Nov 15, 2021 | — | $363.05K | — | — | -$37.48 | — | — | — |
| Q3 2021 Aug 20, 2021 | — | $202.99K | — | — | -$3.75 | — | — | — |
| Q2 2021 May 14, 2021 | — | $2.12K | — | — | -$0.19 | — | — | — |